Delivery Order SPE2DB20D3103-SPE2DB24FN2C9
Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,687.43 Firm Fixed Price delivery order is for the supply of Glatiramer 40 mg/mL syringes, with a completion date of March 4, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of glatiramer 40 mg/ml syringes, a specialty pharmaceutical product, with a potential value of $2,832.12. It is a firm fixed price delivery order contract with a completion date of February 6, 2024. Amerisourcebergen Drug Corp is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Glatiramer 40 mg/ml syringes valued at $5,860.02, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $6,973.17 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Glatiramer 40 mg/ml syringes, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,911.09 firm fixed-price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a medication, with an ultimate completion date of March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product Glatiramer 40 mg/mL syringe. The award has a ceiling value of $2,832.12 and an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,158.51 firm fixed-price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGE, a specialty medication. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Glatiramer 40 mg/ml syringes, valued at $5,083.61. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the agency's pharmaceutical procurement strategy through established contract vehicles....
- The Defense Logistics Agency awarded a delivery order valued at $2,930.01 to AmerisourceBergen Drug Corp for Glatiramer 40 mg/ml syringes, with an ultimate completion date of June 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,834.96 firm-fixed-price delivery order is for the supply of 4565006756 GLATIRAMER 40 MG/ML SYRINGEML, a medical product, with a completion date of June 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...